Literature DB >> 22823

Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists.

E Carlsson, C G Dahlöf, A Hedberg, H Persson, B Tångstrand.   

Abstract

The relative inotropic and chronotropic activity of beta-adrenoceptor agonists was studied in the noradrenaline-depleted, anaesthetized cat. Terbutaline, a selective beta2-adrenoceptor agonist, gave at a certain dose a more pronounced chronotropic than inotropic response, while a new beta1-selective adrenoceptor agonist (-)-H 80/62 produced the same degree of chronotropic and inotropic stimulation. The results indicate that there is some difference between the beta-adrenoceptors in the sinus node mediating chronotropic stimulation and beta-adrenoceptors in the ventricular myocardium mediating stimulation of the contractile force. It has been shown that there are both beta1- and beta2-adrenoceptors in the heart (Carlsson et al., 1972). In the light of this finding it is hypothetized that there are differences in the relative distribution of beta1- and beta2-adrenoceptors in the sinus node and in the myocardium. Athough beta1 is the predominant type of beta-adrenoceptor in both regions, the beta1:beta2 concentration ratio seems to be higher in the myocardium, than in the sinus node.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 22823     DOI: 10.1007/BF00505039

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

Review 1.  A survey of the pharmacological properties of metoprolol in animals and man.

Authors:  B Ablad; K O Borg; E Carlsson; L EK; G Johnson; T Malmfors; C G Regårdh
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  Indications for the existence of two types of cardiac beta-adrenergic receptors.

Authors:  A C Dreyer; J Offermeier
Journal:  Pharmacol Res Commun       Date:  1975-04

3.  Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors.

Authors:  M Knaus; B Pfister; U C Dubach; P R Imhof
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

Review 4.  Recent beta-adrenoreceptor stimulants.

Authors:  R T Brittain; D Jack; A C Ritchie
Journal:  Adv Drug Res       Date:  1970

5.  A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline.

Authors:  J B Farmer; G P Levy; R J Marshall
Journal:  J Pharm Pharmacol       Date:  1970-12       Impact factor: 3.765

6.  Evaluation of the cardiac effects of several beta adrenergic blocking agents.

Authors:  J R Blinks
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

7.  In vivo analysis of adrenergic receptor activity of dobutamine.

Authors:  N W Robie; D O Nutter; C Moody; J L McNay
Journal:  Circ Res       Date:  1974-05       Impact factor: 17.367

8.  Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.

Authors:  B Ablad; E Carlsson; L Ek
Journal:  Life Sci I       Date:  1973-02-01

9.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

10.  Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(T-butylamino)-ethanol. A new sympathomimetic beta-receptor-stimulating agent.

Authors:  H Persson; T Olsson
Journal:  Acta Med Scand Suppl       Date:  1970
View more
  60 in total

1.  Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.

Authors:  E N Juberg; K P Minneman; P W Abel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

2.  The guinea-pig isolated bronchus for the in vitro study of small calibre airway reactivity.

Authors:  C Advenier; J L Freslon
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

3.  Effect of prenalterol in asthmatic patients.

Authors:  C G Löfdahl; N Svedmyr
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

4.  Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

Authors:  A C Tweddel; R G Murray; D Pearson; W Martin; I Hutton
Journal:  Br Heart J       Date:  1982-04

5.  Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.

Authors:  A Hedberg; E Carlsson; E Fellenius; B Lundgren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

6.  Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.

Authors:  H Drexler; H Löllgen; H Just
Journal:  Klin Wochenschr       Date:  1981-06-15

7.  Temperature related effects on the binding characteristics of beta-adrenergic receptor agonists and antagonists by rabbit lung.

Authors:  R J Altiere; J S Douglas; C N Gillis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

8.  Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome.

Authors:  R Ortmann; S Martin; E Radeke; A Delini-Stula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

9.  Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversible beta-adrenoceptor antagonist.

Authors:  K J Broadley; C D Nicholson
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

10.  Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.

Authors:  C Graffner; K J Hoffmann; G Johnsson; P Lundborg; O Rönn
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.